This review provides a summary of the epidemiological data and current treatment strategies for cardiomyopathies and chronic heart failure in the Chinese population.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to high HF hospitalization burden in China; leaves open need for population-specific outcome trials.
Heart failure (HF), a syndrome of clinical symptoms and signs, is the most serious and the final outcome of all heart diseases and as in other parts of the world it is a common cause for admission to hospital in the Chinese population. In this review the epidemiological data on cardiomyopathies, HF and current treatment for chronic HF among people living in China are summarised.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: